August 15, 2025 - 00:29

BayCare's Morton Plant Hospital in Clearwater has introduced groundbreaking technology aimed at enhancing the treatment of breast cancer. This state-of-the-art system is notable for being the first of its kind in Florida, marking a significant advancement in medical care for patients battling this disease.
The new technology is designed to improve the precision of breast cancer diagnosis and treatment, allowing healthcare providers to tailor therapies to individual patient needs more effectively. This innovation not only promises to enhance treatment outcomes but also aims to reduce the physical and emotional toll often associated with traditional cancer therapies.
Healthcare professionals at Morton Plant Hospital are optimistic that this new equipment will lead to earlier detection and more effective management of breast cancer, ultimately improving survival rates. As the hospital continues to invest in advanced medical technologies, it reaffirms its commitment to providing exceptional care and support for patients and their families during their cancer journey.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...